Ted W. Love

Companies

• Caladrius BiosciencesBoard member Sep 28, 2026 to now¹
• Jazz PharmaceuticalsBoard member Dec 10, 2025 to now²
• Gilead SciencesBoard member Feb 6, 2024 to now³
• Structure Therapeutics Inc.Board member Aug 4, 2023 to now⁴
• Royalty Pharma plcBoard member Aug 10, 2020 to now⁵
• SeagenBoard member Aug 18, 2020 to Dec 15, 2023⁶
• Global Blood Therapeutics, Inc.Chief executive officer Feb 3, 2016 to Oct 6, 2022⁷
• Global Blood Therapeutics, Inc.President Feb 3, 2016 to Oct 6, 2022⁷
• Global Blood Therapeutics, Inc.Board member Aug 11, 2015 to Oct 6, 2022⁸
• Global Blood Therapeutics, Inc.Officer Aug 11, 2015 to Aug 4, 2020⁸
• Amicus TherapeuticsBoard member Jun 15, 2012 to Jun 8, 2020⁹
• HUMANIGEN, INCBoard member Aug 10, 2012 to Jul 14, 2015¹⁰
• Savara IncBoard member Sep 7, 2012 to Jun 21, 2013¹¹
• Onyx PharmaceuticalsEVP, R&D Feb 3, 2010 to Jul 27, 2012¹²
• Bio-Rad LaboratoriesBoard member Mar 25, 2010 to Mar 25, 2010¹³
• Oruka Therapeutics, Inc.Board member Mar 7, 2006 to Feb 9, 2010¹⁴
• Oruka Therapeutics, Inc.C.E.O. Aug 2, 2006 to Mar 25, 2008¹⁵
• Oruka Therapeutics, Inc.President Mar 7, 2006 to Mar 7, 2006¹⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RPRoyalty Pharma plc RPRX58,393 shares¹⁶$3.5M at $60.48Jun 5, 2026
• GSGilead Sciences GILD5,484 shares¹⁷$842.8K at $153.68Apr 30, 2026
• JPJazz Pharmaceuticals JAZZ2,389 shares¹⁸$494.6K at $207.05Aug 31, 2026
• CBCaladrius Biosciences LSTA19,260 shares¹⁹$18.9K at $0.98Sep 28, 2026
• Bio-Rad Laboratories BIO0 shares²⁰Mar 25, 2010
• Seagen SGEN0 shares²¹Dec 14, 2023
• GBGlobal Blood Therapeutics, Inc.0 shares²²Oct 5, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 31, 2026Shares withheld for tax 737 shares at $241.39 of Jazz Pharmaceuticals¹⁸
• Aug 31, 2026Shares withheld for tax 6 shares at $244.06 of Jazz Pharmaceuticals¹⁸
• Aug 5, 2026Granted 1,605 shares of Jazz Pharmaceuticals²³
• Jun 5, 2026Granted 4,545 shares of Royalty Pharma plc¹⁶
• Apr 30, 2026Granted 1,146 shares of Gilead Sciences¹⁷
• Feb 26, 2026Granted 1,527 shares of Jazz Pharmaceuticals²⁴
• May 13, 2025Granted 7,614 shares of Royalty Pharma plc²⁵
• May 7, 2025Granted 1,516 shares of Gilead Sciences²⁶
• Jun 7, 2024Granted 9,293 shares of Royalty Pharma plc²⁷
• May 8, 2024Granted 2,310 shares of Gilead Sciences²⁸
• Feb 2, 2024Granted 512 shares of Gilead Sciences²⁹
• Dec 14, 2023Returned to company 4,255 shares at $229.00 of Seagen²¹
• Jun 23, 2023Granted 7,747 shares of Royalty Pharma plc³⁰
• May 31, 2023Granted 2,044 shares of Seagen³¹
• Oct 5, 2022Returned to company 2,500 shares of Global Blood Therapeutics, Inc.²²
• Oct 5, 2022Returned to company 2,500 shares of Global Blood Therapeutics, Inc.²²
• Oct 5, 2022Returned to company 102,000 shares of Global Blood Therapeutics, Inc.²²
• Oct 5, 2022Returned to company 119,650 shares of Global Blood Therapeutics, Inc.²²
• Oct 5, 2022Returned to company 119,650 shares of Global Blood Therapeutics, Inc.²²
• Oct 5, 2022Returned to company 576,318 shares of Global Blood Therapeutics, Inc.²²
• Sep 27, 2022Exercised options 18,291 shares at $16.40 of Global Blood Therapeutics, Inc.³²
• Sep 13, 2022Gift 17,650 shares of Global Blood Therapeutics, Inc.³²
• Sep 13, 2022Gift 17,650 shares of Global Blood Therapeutics, Inc.³²
• Sep 13, 2022Gift 35,300 shares of Global Blood Therapeutics, Inc.³²
• Sep 9, 2022Gift 221,200 shares of Global Blood Therapeutics, Inc.³²